Glaxosmithkline Pharma Peer Comparison

NSE: GLAXO | BSE: 500660

₹2,727.60

up-down-arrow ₹14.20 (0.52%)

As on 20-Nov-2026 15:31IST

Market cap

info icon

₹45,841 Cr

Revenue (TTM)

info icon

₹4,159 Cr

P/E Ratio

info icon

40

P/B Ratio

info icon

24.4

Div. Yield

info icon

2.1 %

Edit peer-selector-edit
Glaxosmithkline Pharma Zydus Lifesciences Dr. Reddy'S Labs Mankind Pharma Aurobindo Pharma
Market cap (₹ Cr)
45,841 1,20,099 1,16,307 1,09,653 1,03,732
Revenue (₹ Cr)
4,159 30,378 33,097 15,379 36,913
Net Profit (₹ Cr)
1,146.54 4,159.00 2,759.70 2,249.69 3,993.05
Net Margin (%)
26.40 13.20 8.03 14.32 10.61
RoE (%)
54.63 16.61 7.30 13.86 10.51
Price to Earnings
39.98 28.73 41.54 48.89 26.00
Price-To-Book
24.37 4.32 3.00 6.24 2.63

Income Statement (₹ Cr)

Liabilities (₹ Cr)

Assets (₹ Cr)

Cashflow (₹ Cr)

Ratios

Profitability Ratios

Growth Ratios

Valuation Ratios

Solvency Ratios

Operating Efficiency Ratios

*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
loading...

Informed fund ideas, better judgment. Every month. Mutual Fund Insight, every month since October 2002.

Take charge. Know more. Keep more. Mutual Fund Insight helps you do all three — every month